Gene signatures of breast cancer development and the potential for novel targeted treatments

Pharmacogenomics. 2020 Feb;21(3):157-161. doi: 10.2217/pgs-2019-0158.
No abstract available

Keywords: TNBC; breast cancer progression; epigenetics; gene signature; hereditary breast cancer; target therapy.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / genetics*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Epigenesis, Genetic / drug effects*
  • Female
  • Humans
  • Molecular Targeted Therapy
  • Neoplastic Syndromes, Hereditary / drug therapy
  • Neoplastic Syndromes, Hereditary / genetics
  • Triple Negative Breast Neoplasms / drug therapy
  • Triple Negative Breast Neoplasms / genetics

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor